GlassScriptPhysician profile
Juan C Mejia
NPI 1588848428
$2,440.18
in general payments reported to CMS, 2019-2025
8 companies · $27.90 in 2025
The $27.90 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $16.93 · 2022: $55.17 · 2023: $117 · 2024: $1,744 · 2025: $27.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,228 · Food and Beverage: $652 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,228.10 |
| Food and Beverage | $652.30 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,047.26 | 2019-2024 | |
| Abbvie INC. | $192.78 | 2019-2025 | |
| Allergan, INC. | $73.52 | 2019 | |
| Janssen Biotech, INC. | $66.75 | 2019-2023 | Stelara |
| Alexion Pharmaceuticals, INC. | $23.31 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.86 | 2019 | |
| Braintree Laboratories, INC. | $14.70 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Mejia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.